Antibiotic prophylaxis in transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma

DOI Web Site Web Site 3 References

Bibliographic Information

Other Title
  • 肝動脈化学塞栓療法時の予防的抗生剤投与に関する検討―経口剤と注射剤の比較―
  • カン ドウミャク カガク ソクセン リョウホウジ ノ ヨボウテキ コウセイザイ トウヨ ニ カンスル ケントウ : ケイコウザイ ト チュウシャザイ ノ ヒカク

Search this article

Abstract

Aim/background: Antibiotic prophylaxis is widely used in transcatheter arterial chemoembolization (TACE) for advanced hepatocellular carcinoma (HCC). The usefulness of oral antibiotic prophylaxis in TACE has not been established. Material/methods: One hundred forty five HCC, 76 were given oral levofloxacin (LVFX) (PO group) and 69 were administrated with cefotiam (CTM) by intravenous infusion as a historical control (DIV group), were enrolled. We investigated the clinical course and backgrounds of both groups, retrospectively. Results: There are no significant differences in clinical backgrounds, periods of hospitalization and administrating antibiotic drugs between both groups. The cost of antibiotic drugs were significant lower in PO than DIV group (3277.1 vs. 11924.4 yen, P<0.01). Conclusion: Oral LVFX was useful and a low cost medication for preventing infection after TACE.

Journal

  • Kanzo

    Kanzo 54 (10), 713-715, 2013

    The Japan Society of Hepatology

References(3)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top